See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated

Peripheral Neuropathy Article Archives

April 2014

Type 2 Diabetes in Youth: How Serious Is It?

While three decades ago it was rare for a child or teen to be diagnosed with type 2 diabetes, today, the American Medical Association (AMA) estimates that there are about 3,700 new cases a year among youth in the United States.

comments 0 comments - Posted Apr 30, 2014

February 2014

Keeping Your Feet Fit for Travel

You're at your destination and ready to see what there is to see. The real question is this: Are you ready to walk?

comments 0 comments - Posted Feb 6, 2014

Skin Cream Could Treat Peripheral Neuropathy

One of the most debilitating risks of diabetes is peripheral neuropathy, which can impact millions of people each year and often leads to amputation.

comments 0 comments - Posted Feb 2, 2014

August 2013

Enzyme Discovery Could Predict Diabetic Neuropathy

Physicians may be able to predict if diabetic patients will develop peripheral neuropathy, thanks to results of new research.

comments 0 comments - Posted Aug 1, 2013

September 2012

FDA Approves New Neuropathy Pain Drug

The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only opioid on the US market that has been approved for treating the condition.

comments 1 comment - Posted Sep 11, 2012

March 2012

Unnecessary, Expensive Tests Performed for Diabetic Neuropathy

One quarter of patients with diabetic neuropathy undergo unnecessary, expensive tests, according to a study by Brian Callaghan, MD, of the University of Michigan Medical School. When Dr. Callaghan and his team looked at 1996-2007 Medicare claims of patients diagnosed with peripheral neuropathy, they found that the most common test performed was an MRI of the brain or spine. There were far fewer instances of glucose tolerance tests. Other tests that were done, but much less often, included fasting glucose levels, A1Cs, vitamin B12 levels, and serum protein electrophoresis.

comments 0 comments - Posted Mar 12, 2012

February 2012

Spotlight on Supplements

Cinnamon, chromium, and alpha-lipoic acid are dietary supplements that have been studied for diabetes management, but are not commonly found in daily multivitamins. Chromium* and cinnamon have the least supportive evidence of efficacy, while some studies have found alpha-lipoic acid to be promising, at least subjectively, in reducing the discomforts of peripheral neuropathy.

comments 1 comment - Posted Feb 12, 2012

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.